MicroRNAs Repair Heart Cells

Researchers identify microRNAs that keep cardiac cells healthy after heart attack, potentially paving the way for future heart regenerating therapies.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Wikipedia, Heikenwaelder Hugo.Cardiac cells lose most of their capacity for proliferation and regeneration shortly after birth, making it difficult for hearts to recover from damage later in life. But researchers have identified four human microRNAs that can stimulate proliferation of adult rodent cardiac cells in culture and help protect against damage during heart attack in vivo, according to a study published today (December 5) in Nature. If the microRNAs work similarly in human cardiac cells, they may have potential as regenerative therapies after heart damage.

“This is a different approach to repairing damaged cardiac tissue,” said Scot Matkovich, a molecular biologist at Washington University in St. Louis who was not involved in the research. In contrast to stem cell-based approaches, which aim to integrate new cells into the heart, microRNAs (miRNAs) could potentially be a way of “waking up existing cardiomyocytes immediately adjacent to an area of [heart] trauma, still in their native environment, so they can proliferate a little further and fill in the gaps,” Matkovich explained.

Shortly after birth, mammalian heart cells lose most of their capacity to proliferate, which makes it difficult to repair damaged heart tissue, following a heart attack, for example. One approach currently being examined is the use of stem cells, differentiated into cardiomyocytes ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Sabrina Richards

    This person does not yet have a bio.
Share
May digest 2025 cover
May 2025, Issue 1

Study Confirms Safety of Genetically Modified T Cells

A long-term study of nearly 800 patients demonstrated a strong safety profile for T cells engineered with viral vectors.

View this Issue
iStock

TaqMan Probe & Assays: Unveil What's Possible Together

Thermo Fisher Logo
Meet Aunty and Tackle Protein Stability Questions in Research and Development

Meet Aunty and Tackle Protein Stability Questions in Research and Development

Unchained Labs
Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Detecting Residual Cell Line-Derived DNA with Droplet Digital PCR

Bio-Rad
How technology makes PCR instruments easier to use.

Making Real-Time PCR More Straightforward

Thermo Fisher Logo

Products

fujirebio-square-logo

Fujirebio Receives Marketing Clearance for Lumipulse® G pTau 217/ β-Amyloid 1-42 Plasma Ratio In-Vitro Diagnostic Test

The Scientist Placeholder Image

Biotium Launches New Phalloidin Conjugates with Extended F-actin Staining Stability for Greater Imaging Flexibility

Leica Microsystems Logo

Latest AI software simplifies image analysis and speeds up insights for scientists

BioSkryb Genomics Logo

BioSkryb Genomics and Tecan introduce a single-cell multiomics workflow for sequencing-ready libraries in under ten hours